论文信息 - .EGFR mutation mediates resistance to EGFR tyrosine kinase inhibitors in NSCLC: From molecular mechanisms to clinical research. - 字舞流文

.EGFR mutation mediates resistance to EGFR tyrosine kinase inhibitors in NSCLC: From molecular mechanisms to clinical research.

Lingyi Kong | Yi-ting Xu | Mingming Liu | Rui-Fang Dong | Jing Bian | Liu-Liu Yuan | Yuan-zheng Xia | Miao-Lin Zhu | Yi-Ting Xu | Yi-ting Xu